40
Participants
Start Date
October 20, 2023
Primary Completion Date
January 31, 2024
Study Completion Date
July 31, 2024
6% aqueous phenol
1.5 mL of aqueous phenol will be injected at each target genicular nerve under ultrasound guidance
MethylPREDNISolone 40 MG
40 mg of methylprednisolone diluted in 5 mL of 0.9% normal saline will be injected inside the knee joint capsule under ultrasound guidance
Intraarticular Knee Placebo
Single injection 1.5 mL of 0.9% normal saline outside the knee joint capsule under ultrasound guidance
Genicular Nerve Placebo
1.5 mL of 0.9% normal saline will be injected subcutaneously at each target genicular nerve under ultrasound guidance
University of Manitoba
OTHER